Search research articles
Contact Us
Filters
Showing results (11-20 of 16) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 16 results.
Clinical Genitourinary Cancer
|
March 10, 2019
A Case of Anti-PD-L1-associated Remitting Seronegative Symmetric Synovitis With Pitting Edema
Jason M Redman, Logan P Rhea, Lisa Cordes, et al.
Molecular Brain
|
August 23, 2015
Insulin and IGF1 signalling pathways in human astrocytes in vitro and in vivo; characterisation, subcellular localisation and modulation of the receptors
Claire J Garwood, Laura E Ratcliffe, Sarah V Morgan, et al.
Clinical Genitourinary Cancer
|
April 25, 2020
Phase 2 Study of Seviteronel (INO-464) in Patients With Metastatic Castration-Resistant Prostate Cancer After Enzalutamide Treatment
Ravi A Madan, Keith T Schmidt, Fatima Karzai, et al.
Journal for Immunotherapy of Cancer
|
March 5, 2021
Clinical and immunologic impact of short-course enzalutamide alone and with immunotherapy in non-metastatic castration sensitive prostate cancer
Ravi A Madan, Fatima Karzai, Renee N Donahue, et al.
Journal for Immunotherapy of Cancer
|
December 6, 2018
Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations
Fatima Karzai, David VanderWeele, Ravi A Madan, et al.
BJU International
|
September 24, 2020
Cabozantinib plus docetaxel and prednisone in metastatic castration-resistant prostate cancer
Ravi A Madan, Fatima H Karzai, Munjid Al Harthy, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 16) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 16 results.
Clinical Genitourinary Cancer
|
March 10, 2019
A Case of Anti-PD-L1-associated Remitting Seronegative Symmetric Synovitis With Pitting Edema
Jason M Redman, Logan P Rhea, Lisa Cordes, et al.
Molecular Brain
|
August 23, 2015
Insulin and IGF1 signalling pathways in human astrocytes in vitro and in vivo; characterisation, subcellular localisation and modulation of the receptors
Claire J Garwood, Laura E Ratcliffe, Sarah V Morgan, et al.
Clinical Genitourinary Cancer
|
April 25, 2020
Phase 2 Study of Seviteronel (INO-464) in Patients With Metastatic Castration-Resistant Prostate Cancer After Enzalutamide Treatment
Ravi A Madan, Keith T Schmidt, Fatima Karzai, et al.
Journal for Immunotherapy of Cancer
|
March 5, 2021
Clinical and immunologic impact of short-course enzalutamide alone and with immunotherapy in non-metastatic castration sensitive prostate cancer
Ravi A Madan, Fatima Karzai, Renee N Donahue, et al.
Journal for Immunotherapy of Cancer
|
December 6, 2018
Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations
Fatima Karzai, David VanderWeele, Ravi A Madan, et al.
BJU International
|
September 24, 2020
Cabozantinib plus docetaxel and prednisone in metastatic castration-resistant prostate cancer
Ravi A Madan, Fatima H Karzai, Munjid Al Harthy, et al.
Page
of 2